NVO · NYSE · Healthcare · Drug Manufacturers - General

Novo Nordisk

—近一月
價格暫不可用
  • 52週區間35.12–64.16
  • 本益比9.46
  • 市值1695.52億

最新消息

載入中...

簡介

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovasc...

novonordisk.com